UPDATE: Jefferies Reiterates Buy Rating, Raises PT on Ventas on Long-Term Value

Loading...
Loading...
In a report published Friday, Jefferies reiterated its Buy rating on Ventas
VTR
, and raised its price target from $72.00 to $78.00. Jefferies noted, “Despite the ~13% return since October, we still see long-term value in VTR, given: 1) a high quality portfolio heavily weighted towards private-pay assets, 2) a strong balance sheet with an attractive cost of capital, and 3) a seasoned management team with significant deal experience, positioning VTR for solid long-term growth. As a result, VTR remains one of our top healthcare REIT picks. Raising PT to $78 and maintain our Buy rating.” Ventas closed on Thursday at $70.78.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsJefferies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...